ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DDDD 4d Pharma Plc

16.36
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 16.36 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

4d Pharma Share Discussion Threads

Showing 13076 to 13098 of 39350 messages
Chat Pages: Latest  530  529  528  527  526  525  524  523  522  521  520  519  Older
DateSubjectAuthorDiscuss
27/10/2020
23:28
Hope so Stig.200 pounds here we come!!!!Peace out
rastamouse
27/10/2020
23:26
And the big "what if" moment could be a combination or all 4 shots coming good one after the other ! That would be a game changer !
thepaddedcell
27/10/2020
23:18
No idea what could be our 'breakout' moment as we don't have a Phase III trial 'success' due

However worth noting Seres's 'success' is a 'success' in inverted commas because their trial was 'underpowered' with only c.200 participants and the FDA have refused Seres' request for a meeting to expedite approval. Seres are having to thus recruit more patients and will have to wait for the extended study to complete before they reach commercialisation

Meanwhile we have a chance of reaching commercialisation milestone prior to them possibly in TWO indications

1. Cancer - owing to safety profile, combination with Industry leader Keytruda/Merck, MD Anderson links to FDA etc there is high chance MRx0518 could be approved in 2021 and rapidly commercialised alongside $20bn p.a. Keytruda

2. Covid - again owing to MRx0004 safety profile, given emergency nature of pandemic, IF MRx0004 demonstrates any efficacy it has the chance to be fast-tracked into commercialisation

Other potential BREAKOUT catalysts could be :-

Any Merck Vaccine - milestone payment or even a positive official progress report

Listing on NASDAQ in January 2021 under ticker LBPS

I make it about 4 shots on goal in the next few months which could give us our Seres type breakout moment

the stigologist
27/10/2020
23:17
Slow and steady wins the race ! Still up around 20% on this time last week.
thepaddedcell
27/10/2020
23:15
From the "UPS" thread .....

AAAA 116p

Today's early drop reached 61.8% Fibonacci retracement the normal point of bounce back, and also the 110p merger terms. Time to bounce back to higher points help by the Covid 19 getting worse.

master rsi
27/10/2020
21:53
In Halloween week a bit spooky how our weekly chart is setting up exactly like Seres MCRB prior to their breakout on Phase III data...

The share price towards the bottom of the weekly Moving Average...

the stigologist
27/10/2020
21:50
Bermudashorts - legend. It feels like a scene from the shining at the moment, scary but you know what is coming.
devonlad
27/10/2020
21:36
We're just days/weeks/months away from deals of this type and/or actual commercial launch and sales into the $200 Billion a year Cancer Therapy market
the stigologist
27/10/2020
21:31
The 4th Annual Next-Gen Immuno-Oncology Congress demonstrates how young this huge market is and the exciting development/combination options.

Great to see 4D will be there hob-nobbing with the Leaders in the space (No other microbiome player attending AFAICS)



30+ experts from academia and industry will be presenting their current work in Immuno-Oncology, Latest updates on regulatory guidelines and approvals, Validation markers for tumor-derived T-cell subpopulations, NextGen T-Cell and CAR-T Cell therapy, Personalized Medicine, Biomarkers and Cancer Immunotherapy

the stigologist
27/10/2020
21:24
Yes - VERY good find.
someuwin
27/10/2020
21:18
Great find Bermudashorts!
ambyth
27/10/2020
21:15
Devonlad

Both Alex Stevenson and Imke Mulder are involved in the January event. Alex Stevenson is on the panel for the European Microbiome Leaders Discussion and Dr Mulder is presenting later in the day - details of her presentation below, last line is interesting:-

MicroRx Single Strain Live-Biotherapeutics: POC Clinical Data and Future Considerations

- From preclinical models to proof of concept in patients
- Next phase of clinical development
- Second generation MicroRx LBPs and new target diseases

bermudashorts
27/10/2020
21:03
January event could be quite interesting.
devonlad
27/10/2020
20:42
Packed schedule in the weeks/months ahead
the stigologist
27/10/2020
20:26
so a woke version of Fingerbobs then
lionheart72
27/10/2020
20:21
The vermin needs to be removed
blueblood
27/10/2020
20:13
Rastamouse is a British animated stop motion children's TV series created by Genevieve Webster and Michael De Souza and produced by Three Stones Media/The Rastamouse Company for CBeebies. The show follows crime busting mouse reggae band Da Easy Crew, who split their time between making music and solving mysteries for Da President of Mouseland..........say no more!
showmethemoneyhoney01
27/10/2020
19:54
50 Day MA at around 1.22Hopefully it should test that and climb above soon.If it does then 1.80 is on again.If not the 1.00 could be tested.
rastamouse
27/10/2020
19:51
https://twitter.com/Share_Talk/status/1321123343211372546?s=20
rastamouse
27/10/2020
19:17
At present, numerous trials are exploring how to manipulate the gut microbiota in an effort to improve clinical outcomes. Several methods are currently being investigated, including the use of prebiotics, probiotics, fecal microbiota transplantation, or capsules loaded with bacteria.

One clinical trial (ClinicalTrials.gov identifier NCT03934827) is actively recruiting multiple solid tumors to investigate a novel biotherapeutic, MRx0518, which is composed of a proprietary strain of bacterium. Patients who have been diagnosed with one of many solid tumors and are amenable to surgical resection are eligible for this study.

hazydaisy
27/10/2020
19:07
Lol Maybe tomorrow you will have a clearerHead
gooner1886
27/10/2020
19:03
Lol.What u do with your boyfriend should be between you and your boyfriend.Peace out
rastamouse
27/10/2020
18:12
Nothing underpins nothing
rastamouse
Chat Pages: Latest  530  529  528  527  526  525  524  523  522  521  520  519  Older

Your Recent History

Delayed Upgrade Clock